Skip to main content

GSA CAPITAL PARTNERS LLP

Position in ABCL — AbCellera Biologics Inc.

CIK 1362033 LONDON, X0

Position in ABCL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,659,254
+$590,289 QoQ
Shares Held
211,370
-0.5% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#42
of 150 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABCL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. ABCL ranks #16 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABCL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,659,254 211,370
2025-09-30 $1,068,965 212,518
2025-06-30 $818,188 238,539
2025-03-31 $595,175 266,895
2024-12-31 $1,726,394 589,213
2024-09-30 $628,851 241,866
2024-06-30 $65,602 22,163
2024-03-31 $390,123 86,120
2023-12-31 $2,002,325 350,670
2023-09-30 $672,474 146,190
2023-06-30 $69,031 10,686
2022-12-31 $1,133,486 111,894
2022-06-30 $729,162 68,466
2022-03-31 $165,633 16,988